A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Acne Vulgaris
Trial details
- Registry ID
- NCT04856917
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as ANB019
| No regulatory events match this view.This does not mean no FDA events have occurred. |